Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.
about
Reducing neurodevelopmental disorders and disability through research and interventionsThe PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral DrugsChanges in Fertility at the Population Level in the Era of ART in Rural Malawi.HIV-exposed infants: rethinking care for a lifelong condition.Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIVSafety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected MothersAcylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United StatesAtazanavir exposure in utero and neurodevelopment in infants: a comparative safety study.Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants.Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free ChildrenPerinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead.Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications.Blood lead levels and neurodevelopmental function in perinatally HIV-exposed, uninfected children in a US-based longitudinal cohort study.Nevirapine extended-release formulation tablets in HIV-1-infected children--long-term follow-up.Neurodevelopmental outcome of HIV-exposed but uninfected infants in the Mother and Infants Health Study, Cape Town, South Africa.Quality of caregiving is positively associated with neurodevelopment during the first year of life among HIV-exposed uninfected children in Uganda.Risk for Speech and Language Impairments in Pre-school Aged HIV-Exposed Uninfected Children with in utero Combination Antiretroviral Exposure.Effect of Caregiver Training on the Neurodevelopment of HIV-Exposed Uninfected Children and Caregiver Mental Health: A Ugandan Cluster-Randomized Controlled Trial.In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana.Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015
P2860
Q22337241-4E1E3DD5-CC67-4629-86E0-C43DD87A8953Q26744617-E3ACC1F1-1F85-470D-8563-2CE243AC284EQ33832976-FDE91EE1-35BE-4B92-9D7A-D42554AFE613Q33871174-C30B186F-A3BD-4FBB-AFC3-4DF962BFD213Q34005836-888ACF8F-15A3-4ADB-8D1F-D02F3E5240B0Q34440361-6283A650-C9BE-46B1-934D-A96D9E0855F8Q36073155-EA8A3449-4512-43A1-B89C-D1B4AE33BCC4Q36756151-ECC0E2FF-1BA2-45D4-BD2F-2881C11E2F10Q36853210-0BF6BFD1-711F-4F16-9B58-CEE0866B4CC6Q36951911-97562800-5FE4-47AC-BAD6-2C63B21C893FQ37202019-A37121DC-7FC7-442B-B680-0D8D8478AFCCQ37342120-E386FB52-6C9D-4441-A8C8-38A451819CF6Q37597830-3B5F6335-526A-4FE1-B3D1-16354A157DDEQ37691000-2374E2FF-E130-492D-A14D-881C38BEDD37Q38201765-CE793A35-1C34-4140-8ED4-DF4B0BC4B448Q40040103-77844B58-C2A1-4BBC-86C8-EBFFC1073B10Q40221645-A106A8FE-81BC-4BFB-A503-6DEA54AD158BQ40283318-F5F0B578-CD29-419A-BEA7-F60E05F7661FQ40794247-DA9EE1DF-9DFE-41A1-B851-344440CCC7C0Q46868578-AB55BFA5-73A7-4BD1-8743-8B7EEBF30BEBQ47180418-FB2CA165-F462-42B8-9ABF-22B19926B308Q47185150-F7113D4F-BDEE-4CFF-8080-23FC1E3C5250Q47602806-523CEC5B-8E02-42FC-82AE-D8A6033E660DQ51365493-C81E1C1A-239F-406D-A0CC-0E6B2D9836C3Q57826130-3C3F9AFA-DD3A-4394-B003-85EF5259E673
P2860
Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@en
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@nl
type
label
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@en
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@nl
prefLabel
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@en
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@nl
P2093
P2860
P1476
Safety of perinatal exposure t ...... lopmental outcomes in infants.
@en
P2093
Betsy Kammerer
Kathleen Malee
Kenneth Rich
Molly L Nozyce
Paige L Williams
Patricia A Garvie
Patricia A Sirois
Pediatric HIVAIDS Cohort Study
Russell B Van Dyke
Yanling Huo
P2860
P304
P356
10.1097/INF.0B013E318284129A
P577
2013-06-01T00:00:00Z